Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Growth”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT05304962
What this trial is testing

FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Regor Pharmaceuticals Inc. 64
Testing effectiveness (Phase 2)Study completedNCT00684983
What this trial is testing

Capecitabine and Lapatinib Ditosylate With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB-IV Breast Cancer

Who this might be right for
HER2 Positive Breast CarcinomaRecurrent Breast CarcinomaStage IIIB Breast Cancer AJCC v7+2 more
National Cancer Institute (NCI) 64
Testing effectiveness (Phase 2)Study completedNCT00600054
What this trial is testing

Phase 2 Study of Nimotuzumab in Pediatric Recurrent Diffuse Intrinsic Pontine Glioma

Who this might be right for
Recurrent Diffuse Pontine Gliomas
YM BioSciences 44
Testing effectiveness (Phase 2)Looking for participantsNCT07427394
What this trial is testing

Study to Evaluate the Safety and Tolerability of Camizestrant in Combination With Atirmociclib in Women With Advanced Breast Cancer

Who this might be right for
Advanced Breast Cancer
AstraZeneca 24
Not applicableStudy completedNCT00834028
What this trial is testing

Recurrence and Distant Metastases in Hepatocellular Carcinoma Treated by Transcatheter Arterial Chemoembolization

Who this might be right for
Hepatocellular Carcinoma
Kaohsiung Medical University Chung-Ho Memorial Hospital 60
Not applicableNot Yet RecruitingNCT07647692
What this trial is testing

Deep Learning Time-Series Prediction of Long-Term Growth Patterns of Pulmonary Ground-Glass Nodules Using Serial CT

Who this might be right for
Pulmonary NodulesLung NeoplasmsAdenocarcinoma of Lung
Peking University People's Hospital 4,750
Not applicableUnknownNCT03521245
What this trial is testing

Molecular Pathway Activation Markers Predicting Efficacy of Trastuzumab Therapy for HER2-positive Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
OmicsWay Corp. 40
Not applicableStudy completedNCT02954471
What this trial is testing

Study of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Participants With Early/Metastatic Breast Cancer in Saudi Arabia

Who this might be right for
Breast Cancer
Hoffmann-La Roche 351
Not applicableNot Yet RecruitingNCT07306325
What this trial is testing

Ultrasound in Predicting Difficult Intubation in Acromegaly Patients

Who this might be right for
Acromegaly Due to Pituitary AdenomaDifficult IntubationAirway Ultrasonography
Başakşehir Çam & Sakura City Hospital 34
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06672068
What this trial is testing

TY-9591 With Chemotherapy as 1st Line Treatment in Patients With Mutated Epidermal Growth Factor Receptor NSCLC

Who this might be right for
NSCLC
TYK Medicines, Inc 60
Early research (Phase 1)Study completedNCT00375310
What this trial is testing

Phase I Study of Gemcitabine, Sorafenib and Radiotherapy in Patients With Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic CancerAdenocarcinoma of the Pancreas
Indiana University 27
Testing effectiveness (Phase 2)UnknownNCT03778008
What this trial is testing

Recombinant Bovine Basic Fibroblast Growth Factor for the Treatment of Radiation Induced Oral Mucositis

Who this might be right for
Stomatitis
Second Affiliated Hospital of Nanchang University 90
Early research (Phase 1)Study completedNCT00820417
What this trial is testing

Pharmocokinetic/Pharmacodynamic (PK/PD) Study of the Combination Cetuximab/Gefitinib

Who this might be right for
Colorectal CancerHead and Neck CancerNon Small Cell Lung Cancer (NSCLC)
Harrison Clinical Research 63
Testing effectiveness (Phase 2)Study completedNCT00020917
What this trial is testing

Cetuximab Plus Combination Chemotherapy in Treating Patients With Stage IV Colorectal Cancer

Who this might be right for
Colorectal Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT07518160
What this trial is testing

JS212 Plus JS111 in EGFR-Mutant Advanced NSCLC: A Phase II Study

Who this might be right for
Locally Advanced, Metastatic, or Recurrent Non-small Cell Lung Cancer (NSCLC) Harboring Epidermal Growth Factor Receptor (EGFR) Mutations
Shanghai Junshi Bioscience Co., Ltd. 35
Testing effectiveness (Phase 2)Study completedNCT02924376
What this trial is testing

Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - (FIGHT-202)

Who this might be right for
Cholangiocarcinoma
Incyte Corporation 147
Testing effectiveness (Phase 2)WithdrawnNCT00601991
What this trial is testing

A Multi-Center Phase 2 Study of VEGF Trap as a Single Agent in Acute Myeloid Leukemia

Who this might be right for
Leukemia
Vanderbilt-Ingram Cancer Center
Not applicableStudy completedNCT00978926
What this trial is testing

The Pharmacodynamic Effects of Anti-Vascular Endothelial Growth Factor Therapy in Patients With Advanced Malignancies

Who this might be right for
Advanced Malignancy
National University Hospital, Singapore
Early research (Phase 1)Study completedNCT02734160
What this trial is testing

Galunisertib (LY2157299) and Durvalumab (MEDI4736) in Participants With Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
Eli Lilly and Company 37
Not applicableStudy completedNCT04671615
What this trial is testing

Understand the Treatment Patterns and Patients and Their Clinical Outcomes Who Are Taking Palbociclib in a Real Life Setting in Israel.

Who this might be right for
Metastatic Breast Cancer
Pfizer 559
Next Page